FMR1 has been previously identified as a promoter of PCa progression via the m6A-mediated circRBM33-FMR1 complex and has also been found to be correlated with a poor prognosis in the disease-free survival of PCa patients [47]. Here, FMR1 is linked to posterior cortical atrophy.